Impact of Vancomycin trough levels monitoring on uncomplicated methilcillin-resistant Staphylococcus aureus bacteremia in chronic kidney disease on hemodialysis, retrospective cohort

Abstract Background CKD patients on hemodialysis (HD) with Staphylococcus aureus (SA) bacteremia present high morbidity, mortality and increased risk of MRSA. Vancomycin is the antibiotic of choice in these cases, it has a narrow therapeutic margin and inadequate dosage generates a risk of toxicity,...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Julian Felipe Ramirez-Osorio, Juan Esteban Velez-Hernandez, Nathalia Fernandez-Castaño, David Felipe Rojas-Hernandez, Fabian Jaimes
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2024-06-01
Sarja:	BMC Infectious Diseases
Aiheet:	CKD-HD Bacteremia Vancomycin Trough levels MRSA
Linkit:	https://doi.org/10.1186/s12879-024-08984-z
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!